In addition, IHC staining of tumour sections with anti-CD31 antibodies specific for endothelial cells was performed to determine whether the combination treatment affected tumour vasculature and, in particular, the number of vessels present in the tumour. This evidence concerns the gene PECAM1 and neoplasm.